Funding for this research was provided by:
Meda Pharma GmbH & Co. KG, a Viatris Company
Meda Pharma S.p.A, a Viatris Company
Article History
Received: 20 October 2022
Accepted: 2 March 2023
First Online: 1 April 2023
Declarations
:
: FF is an employee of Meda Pharma S.p.A., <i>a Viatris Company</i>. IF is an employee of Meda Pharma GmbH & Co. KG, <i>a Viatris Company</i>. LG has served as a consultant for Viatris. SM has no competing interests.
: This is an in vitro study and did not require ethics approval.
: Not applicable.
: Not applicable.